1. Home
  2. KALA vs LXEH Comparison

KALA vs LXEH Comparison

Compare KALA & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • LXEH
  • Stock Information
  • Founded
  • KALA 2009
  • LXEH 2001
  • Country
  • KALA United States
  • LXEH China
  • Employees
  • KALA N/A
  • LXEH N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • LXEH Other Consumer Services
  • Sector
  • KALA Health Care
  • LXEH Real Estate
  • Exchange
  • KALA Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • KALA 26.2M
  • LXEH 25.1M
  • IPO Year
  • KALA 2017
  • LXEH 2020
  • Fundamental
  • Price
  • KALA $3.52
  • LXEH $2.00
  • Analyst Decision
  • KALA Strong Buy
  • LXEH
  • Analyst Count
  • KALA 3
  • LXEH 0
  • Target Price
  • KALA $14.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • KALA 55.2K
  • LXEH 343.6K
  • Earning Date
  • KALA 05-14-2025
  • LXEH 06-10-2025
  • Dividend Yield
  • KALA N/A
  • LXEH N/A
  • EPS Growth
  • KALA N/A
  • LXEH N/A
  • EPS
  • KALA N/A
  • LXEH N/A
  • Revenue
  • KALA N/A
  • LXEH $4,493,795.00
  • Revenue This Year
  • KALA N/A
  • LXEH N/A
  • Revenue Next Year
  • KALA N/A
  • LXEH N/A
  • P/E Ratio
  • KALA N/A
  • LXEH N/A
  • Revenue Growth
  • KALA N/A
  • LXEH N/A
  • 52 Week Low
  • KALA $2.92
  • LXEH $1.53
  • 52 Week High
  • KALA $11.20
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • KALA 42.83
  • LXEH 34.30
  • Support Level
  • KALA $3.67
  • LXEH $1.90
  • Resistance Level
  • KALA $4.16
  • LXEH $2.15
  • Average True Range (ATR)
  • KALA 0.31
  • LXEH 0.36
  • MACD
  • KALA 0.05
  • LXEH 0.43
  • Stochastic Oscillator
  • KALA 34.20
  • LXEH 26.67

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: